Eckert & Ziegler BEBIG


Dr. Harald Hasselmann
Managing Director

Dr. Harald Hasselmann, born in Hamburg, has gained extensive experience at various international pharmaceutical companies. He was head of controlling for Europe at Bayer Pharma, managing director at Schering’s Hungarian subsidiary and director of the Berlin-based biotech company metaGen. He has held various positions in large and medium-sized healthcare companies and has an excellent track record in sales, controlling and implementing restructuring measures. With effect from October 1, 2015, Dr. Hasselmann became Managing Director for Sales and Finances of the Eckert & Ziegler BEBIG GmbH. In June 2016, he was elected in the Board of Directors of the Eckert & Ziegler AG.

Dr. Dirk W. Becker

Managing Director

Dr. Dirk Becker, born in Karlsruhe, with a background in physics is a medical physics expert. After his PhD in radiochemistry at the German Cancer Research Center (DKFZ) in Heidelberg he worked for the TRIUMF PET program at the University of British Columbia, Vancouver, Canada. After his relocation to Austria he was head of the ARGOS Zyklotron GesmbH, Klagenfurt and worked as deputy medical physics expert at the Klagenfurt Regional Hospital. In 2008, Dr. Becker started at Eckert & Ziegler Radiopharma GmbH as head of operations for the GalliaPharm® radionuclide generator. In 2014 he became acting Qualified Person and in 2019 authorized signatory for Eckert & Ziegler Radiopharma GmbH. With effect of December 10th, 2020, Dr. Becker was appointed as Managing Director for the radioactive operations of the Eckert & Ziegler BEBIG GmbH.